Wells Pharma of Houston, LLC – 713015 – 11/07/2025
November 25, 2025FDA approves durvalumab for resectable gastric or gastroesophageal junction adenocarcinoma
November 25, 2025
Cosmetics
Drugs
Medical Devices
Radiation-Emitting Products
Tobacco
Vaccines, Blood, Biologics
The Center for Biologics, Evaluation and Research’s (CBER) Office of Cellular, Tissue and Gene Therapies (OCTGT) web page for industry education contains information on OCTGT-regulated products. Products regulated by OCTGT include gene therapy, tumor vaccines, xenotransplantation, stem cells, human tissue for transplantation, combination products, bioengineered tissues and certain medical devices.
General
